PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oliba, Rome, Italy.\', \'Catholic University of the Sacred Heart, Rome, Italy.\', \'HEC, 1, Rue de la Liberation Jouy en Josas, Paris, France. alessandro.monaco@hec.edu.\', \'Division of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm, Sweden.\', \'Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.\', \'Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.\', \'Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.\', \'CNR-Neuroscience Institute, Aging Branch, Padua, Italy.\', \'Department of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva, Switzerland.\', \'Pfizer GEP SLU, Upjohn, Madrid, Spain.\', \'Medical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens, Greece.\', \'Upjohn (Division of Pfizer), Surrey, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40520-020-01601-4
?:hasPublicationType
?:journal
  • Aging clinical and experimental research
is ?:pmid of
?:pmid
?:pmid
  • 32458356
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all